BREAKING NEWS: Peptides are coming In July, the FDA is reviewing BPC 157, TB 500, Semax, Epitalon and more. The meeting will be open to the public. The peptide era begins. BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO System Orthopedic Use of BPC 157 Sports Med Review